Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AcuNetx, Inc.
AcuNetx Files 10KSB Showing Continued Improvement & Growth
April 18th, 2008
AcuNetx, Inc. (OTCBB:ANTX), announced that it has filed its year ending December 31, 2007 10KSB. Unit sales of its products increased 35% from 2006 with overall gross profit improving from $1,608,796 in 2006 to $1,960,627 in 2007. The expenditure controls put into place in early 2007 resulted in an 89% decrease in the company's net loss, from $8,223,391 in 2006 to $905,070 in 2007. Selling, general and administrative expenses also significantly decreased by 37%, from $4,062,300 in 2006 to $2,586,411 in 2007. Another important business metric was year-end net accounts receivable which decreased 84% from the prior year. The company's HawkEye(TM) eye observation and...
Source: Health Business Week (2008-04-18)
|
